Related by context. All words. (Click for frequent words.) 75 premenopausal women 71 premenopausal 71 premenopausal breast cancer 71 post menopausal 70 postmenopausal women 68 postmenopausal 67 polycystic ovary syndrome PCOS 66 postmenopausal breast cancer 66 tibolone 66 perimenopausal women 65 endometrial cancer 64 oophorectomy 64 undergone hysterectomy 64 testosterone supplementation 63 spontaneous preterm delivery 63 folate intake 63 irregular menstrual cycles 62 vasomotor symptoms 62 hormone therapy estrogen 62 menopausal hormone therapy 62 hydroxyvitamin D levels 62 anovulatory infertility 62 MetS 62 postmenopausal hormone therapy 62 dietary calcium intake 62 polycystic ovary syndrome 62 endometrial cancers 62 calcium supplementation 61 lipid lowering therapy 61 elevated CRP 61 subclinical hypothyroidism 61 folate supplementation 61 estrogen therapy 61 estrogen receptor negative 61 colorectal adenoma 61 endometrial hyperplasia 61 BRCA1 mutations 61 colorectal adenomas 61 SHBG levels 60 bisphosphonate 60 recurrent miscarriage 60 estrogen 60 telomere lengths 60 cardiovascular mortality 60 CLA supplementation 60 dysglycemia 60 estrogen progestin therapy 60 lignan intake 60 PMDD 60 menopausal symptoms 60 subclinical atherosclerosis 60 serum IGF 60 nonpregnant women 60 lobular cancer 60 BRCA1 mutation carriers 60 ovarian hormones 60 symptomatic fibroids 60 spontaneous preterm birth 60 atypical hyperplasia 60 BRCA mutations 59 vertebral fracture 59 tamoxifen 59 GnRH agonists 59 LUTS 59 postmenopausal hormones 59 hypogonadal 59 polycystic ovaries 59 androgen deficiency 59 endogenous estrogen 59 intravenous bisphosphonates 59 adjuvant chemotherapy 59 tumor histology 59 breast cancer recurrence 59 chronic prostatitis 59 plasma folate 59 parous women 59 recurrent VTE 59 advanced adenomas 59 BRCA gene mutations 59 undergone hysterectomies 59 salpingo oophorectomy 59 adenoma 59 osteoporotic fracture 59 urinary symptoms 59 hypogonadal men 59 elevated triglyceride levels 59 lipid levels 59 narcolepsy cataplexy 59 selenium intake 59 serum cholesterol 59 gestational hypertension 59 anovulation 58 cerebral microbleeds 58 hormone therapy HT 58 #mg/dL [001] 58 gallstone disease 58 menopause 58 spine fractures 58 obese postmenopausal 58 hypercholesterolaemia 58 lobular breast cancer 58 T1DM 58 statin therapy 58 venous thrombosis 58 beta blocker therapy 58 haemorrhagic stroke 58 folate deficiency 58 undergone radical prostatectomy 58 thyroid hormone levels 58 polycystic ovarian syndrome PCOS 58 thiazide diuretics 58 anastrozole 58 elevated hsCRP 58 estradiol 58 hypercholesterolemia 58 denser breasts 58 pCR 58 colorectal neoplasia 58 mIU L 58 subclinical hyperthyroidism 58 endometrial carcinoma 58 epithelial ovarian cancer 58 serum vitamin D 58 thyroxine 58 statins 58 Wactawski Wende 58 Health Initiative WHI 58 mild gestational diabetes 58 BRCA2 mutation carriers 58 osteopenic 58 normotensive 58 breast carcinoma 58 bilateral oophorectomy 58 dutasteride 58 invasive breast cancer 58 ovarian function 58 BRCA mutation carriers 58 artery calcification 58 BRCA carriers 58 endometriosis ovarian cysts 58 nondepressed 58 coronary calcification 58 soy isoflavones 58 beta carotene supplementation 58 HER2 positive cancers 58 varicocele 58 overt hypothyroidism 58 adrenal function 58 oral contraceptive pills 58 serum testosterone 57 elevated LDL cholesterol 57 nonvertebral fracture 57 LDL cholesterol levels 57 enlarged prostates 57 BRCA mutation 57 distal colon cancer 57 knee OA 57 adenoma recurrence 57 CC genotype 57 Clinical Endocrinology & 57 transferrin saturation 57 serum calcium 57 serum lipid levels 57 breast tenderness 57 prostate cancer CaP 57 venous thromboembolism 57 prostate cancer PCa 57 axillary lymph nodes 57 mammographic density 57 strontium ranelate 57 serum calcium levels 57 postoperative mortality 57 exemestane 57 amenorrhea 57 hip BMD 57 BRCA2 mutations 57 antihypertensive therapy 57 hormonal therapy 57 acrylamide intake 57 Adjuvant chemotherapy 57 dose oral contraceptives 57 magnesium intake 57 beta carotene supplements 57 hormone therapy 57 atherogenic dyslipidemia 57 preoperative chemotherapy 57 calcium intake 57 folic acid supplementation 57 synthetic progestin 57 asymptomatic carotid stenosis 57 Heavy menstrual bleeding 57 perimenopausal 57 paricalcitol 57 oestradiol 57 cyclic HMB 57 thyrotropin levels 57 Sexual dysfunction 57 HNSCC 57 carotid IMT 57 vaginal atrophy 57 DMPA 57 ovulatory infertility 57 ductal breast cancer 57 osteoporotic 57 Calcium intake 57 primary ovarian insufficiency 57 testicular cancers 57 urothelial cancer 57 mammary tumors 57 slow metabolizers 57 advanced adenoma 57 cervical lesions 57 colon tumors 57 TZDs 57 bisphosphonates 57 knee osteoarthritis 56 nonvertebral fractures 56 abnormal glucose tolerance 56 dyslipidaemia 56 premenstrual syndrome PMS 56 hot flushes 56 adiponectin 56 metabolic syndrome 56 chlamydial infection 56 oral bisphosphonates 56 menopausal women 56 basal cell nevus syndrome 56 preterm delivery 56 CARDIA 56 postmenopausal hormone 56 vitamin D supplementation 56 hypertensive patients 56 NATRECOR R 56 bowel polyps 56 nonfasting triglyceride levels 56 SSRIs 56 urinary tract symptoms LUTS 56 bowel cancers 56 polycystic ovarian syndrome 56 prepubertal 56 osteoporotic fractures 56 nulliparous women 56 serum testosterone levels 56 undergoing radical prostatectomy 56 glycemic diet 56 Prostate Lung Colorectal 56 depressive symptoms 56 fructose diet 56 testicular tumors 56 prescribed statins 56 atypical fractures 56 microbleeds 56 Femara letrozole 56 androgen deprivation 56 thromboembolic 56 folic acid supplement 56 tamoxifen therapy 56 observational studies 56 prolactin levels 56 adjuvant radiation 56 androgen therapy 56 oral contraceptives 56 SHBG 56 benign breast 56 liver transplant recipients 56 antigen PSA 56 microvascular complications 56 highest tertile 56 abnormal Pap test 56 cerebral infarction 56 breastfed infants 56 ovulatory cycles 56 Digital Mammographic Imaging 56 hot flashes 56 ductal cancer 56 menarche 56 solifenacin 56 serum uric acid 56 biochemical recurrence 56 hormone receptor negative 56 AVODART 56 localized prostate cancer 56 elevated triglycerides 56 valproate 56 Dietary Modification Trial 56 hypocaloric diet 56 premature menopause 56 Leitzmann 56 lipid abnormalities 56 atypical ductal hyperplasia 56 contralateral breast cancer 56 thromboembolic disease 56 waist circumferences 56 aromatase inhibitors AIs 56 nondiabetic 56 Postmenopausal 56 endometriosis 56 breast cancers 56 migraineurs 56 FSAD 56 colorectal polyps 56 lowering LDL cholesterol 56 fluvastatin 56 prednisone prednisolone 56 aromatase inhibitor 56 amenorrhoea 56 adjuvant radiotherapy 56 HIV seronegative 56 heavy menstrual bleeding 56 progestogen 56 confidence interval #.#-#.# 56 nifedipine 56 advanced neoplasia 56 BENICAR HCT 56 ovulation induction 56 faulty BRCA genes 56 prehypertensive 56 subtrochanteric 56 carotid stenosis 56 dietary fiber intake 56 Health Initiative Observational 56 troponin T 55 BRCA2 carriers 55 iron deficient 55 randomized controlled trials 55 Cholesterol Levels SPARCL 55 oral contraceptive pill 55 selenium supplementation 55 loop diuretics 55 primary hypercholesterolemia 55 thromboembolic events 55 pre eclamptic 55 vertebral fractures 55 invasive carcinoma 55 naturally occurring estrogen 55 colorectal cancer incidence 55 serum concentrations 55 sodium valproate 55 thyrotropin 55 lobular involution 55 Prostate Cancer Prevention 55 Estradiol 55 hydroxyvitamin D concentrations 55 fragility fracture 55 dysmenorrhea 55 sulphonylureas 55 stable angina 55 atypical femur fractures 55 adjunctive ABILIFY 55 SSRI antidepressants 55 VaD 55 creatine supplementation 55 pathologic fractures 55 calcium intakes 55 carotid atherosclerosis 55 hypertensives 55 dose aspirin 55 bladder cancers 55 ginkgo biloba extract 55 OAB symptoms 55 serum PSA 55 lipid lowering drugs 55 folic acid intake 55 BRCA gene mutation 55 macrovascular disease 55 HER2 positive tumors 55 recurrent miscarriages 55 folate supplements 55 plasma selenium 55 recurrent venous thromboembolism 55 atypia 55 epithelial ovarian 55 HGPIN 55 operable breast cancer 55 statin 55 Subgroup analyzes 55 nondrinkers 55 singleton pregnancies 55 uterine cancers 55 genistein 55 differentiated thyroid 55 periprocedural MI 55 thyroid dysfunction 55 calcium supplements 55 microalbuminuria 55 APTIVUS r 55 postmenopausal estrogen 55 uterine fibroids 55 lipid lowering medications 55 bacterial vaginosis 55 CVD mortality 55 aromatase inhibitor therapy 55 abnormal lipid 55 ischemic stroke 55 estrogen deficiency 55 serum phosphate 55 triacylglycerol concentrations 55 neurodevelopmental outcomes 55 polyp recurrence 55 dietary fat 55 arterial stiffening 55 DAPT 55 ximelagatran 55 serum ferritin 55 iodine intake 55 HSDD 55 teriparatide 55 recurrent ovarian cancer 55 metabolic syndrome MetS 55 teratogenic 55 leptin deficient mice 55 bone mineral 55 abnormal Pap smears 55 preventive mastectomies 55 potentially modifiable 55 colorectal bowel 55 obese adolescents 55 fasting triglyceride levels 55 intestinal polyps 55 phytoestrogen 55 tricyclic antidepressants 55 homocysteine concentrations 55 azoospermia 55 erectile difficulties 55 glitazones 55 abnormal mammogram 55 hormone estradiol 55 cilostazol 55 postmenopausal hormone replacement 55 abdominal adiposity 55 uterine tumors 55 mycophenolate mofetil 55 elevated depressive symptoms 55 anticonvulsant medications 55 albuminuria 55 RLS symptoms 55 mineral density 55 testicular germ cell 55 randomized trials 55 singleton pregnancy 55 Hypoactive Sexual Desire Disorder 55 Oral contraceptives 55 placebo controlled clinical 55 uric acid levels 55 urinary incontinence 55 randomized clinical 55 folate 55 ovarian cancer 55 highest quintile 55 LQTS 55 non fasting triglycerides 55 subfertility 55 precocious puberty 55 systolic BP 55 vitamin D inadequacy 54 oxycodone CR 54 Hashimoto thyroiditis 54 abnormal mammograms 54 fasting glucose levels 54 underwent radical prostatectomy 54 cardio metabolic 54 macroalbuminuria 54 aldosterone antagonist 54 statin medications 54 lasofoxifene 54 postmenopause 54 patients undergoing CABG 54 adiponectin levels 54 bisphosphonate drugs 54 HbA1c levels 54 anti androgen 54 dietary questionnaires 54 dietary intakes 54 probiotic supplementation 54 EBRT 54 SRBD 54 ALT flares 54 estrogen progestin combination 54 Polycystic Ovary Syndrome 54 neoadjuvant 54 desire disorder HSDD 54 candesartan 54 Young Adults CARDIA 54 hereditary breast cancer 54 paclitaxel eluting stents 54 estrogen pills 54 flutamide 54 dose ionizing radiation 54 urolithiasis 54 hsCRP levels 54 VADT 54 systolic hypertension 54 dietary calcium 54 osteopenia 54 cranial irradiation 54 lifetime abstainers 54 thrombocytopenic 54 tamoxifen raloxifene 54 GSTT1 54 GBA mutations 54 premenstrual symptoms 54 APOE e4 54 nonfasting triglycerides 54 varicoceles 54 systemic lupus erythematosus SLE 54 glandular tissue 54 breast tissue 54 nonmelanoma skin cancers 54 venous blood clots 54 Postmenopausal Women 54 recurrent UTI 54 knee osteoarthritis OA 54 N telopeptide 54 colorectal carcinoma 54 triglyceride levels 54 Winkelmayer 54 plus progestin hormone 54 B7 H3 54 antihypertensive medications 54 serum creatinine levels 54 menstrual irregularities 54 adenomas 54 serum selenium 54 PHPT 54 isoflavone intake 54 thromboembolism 54 Screening Trial DMIST 54 antidiabetic drugs 54 Triglyceride levels 54 CARDIA study 54 hormones estrogen 54 umol L 54 NSAIDs 54 macrovascular 54 Bairey Merz 54 hemodilution 54 β blockers 54 preeclampsia 54 Ovary removal 54 Clinical Endocrinology 54 serum triglycerides 54 poor metabolizers 54 BMD measurements 54 #.#ng/ml 54 CHD mortality 54 colorectal neoplasms 54 dysfunctional voiding 54 placebo controlled trials 54 ibandronate 54 hip fracture 54 HER2 positive breast cancer 54 Netherlands Cohort Study 54 recurrent atrial fibrillation 54 leiomyomas 54 cardio protective 54 plasma lipid 54 severe psoriasis 54 colorectal cancer 54 Screening Trial 54 colorectal polyp 54 multivariable adjusted 54 vulvar pain 54 decreased libido 54 aminotransferases 54 fragility fractures 54 chorioamnionitis 54 abdominal obesity 54 ATACAND 54 migraine sufferers 54 postnatally 54 d4T 54 GH deficient 54 hemoglobin A1c levels 54 adiponectin concentrations 54 untreated celiac disease 54 hip fractures 54 incidentalomas 54 endometrial thickness 54 lymph node removal 54 familial hypercholesterolemia 54 LYSTEDA 54 renal cell carcinomas 54 MMSE scores 54 colorectal liver metastases 54 oral antidiabetic medication 54 gestational diabetes mellitus 54 endometrial 54 genetic variants associated 54 extrapyramidal symptoms 54 rimonabant #mg 54 thyroid nodules 54 abdominally obese 54 venlafaxine Effexor 54 nondiabetic patients 54 elevated serum creatinine 54 tamsulosin 54 perimenopause 54 adenomatous polyps 54 luteal phase 54 fibroids endometriosis 54 clinically insignificant 54 alpha carotene 54 axillary lymph node dissection 54 estrone 54 Hilakivi Clarke 54 Invasive Breast Cancer 54 severe menopausal symptoms 54 eribulin 54 modifiable risk 54 Prostatitis 54 lumbar spine BMD 54 hypertension 54 estrogen receptor positive 54 hirsutism 54 inflammatory polyarthritis 54 kidney transplant recipients 54 stone formers 54 axillary dissection 54 longitudinal cohort study 54 HIV uninfected 54 pregabalin 54 homocysteine levels 54 HER2 amplification 54 ALND 54 ovarian cancers 54 vascular dysfunction 54 lamotrigine 54 folic acid supplements 54 thrombophilia 54 seminoma 54 Hormone therapy 54 cosmetic breast implants 54 overactive bladder symptoms 54 BRCA2 mutation 54 mild analgesics 54 adjunctive placebo 54 breast endometrial 54 body fatness 53 ALCL 53 treat menopausal symptoms 53 NAFLD 53 letrozole 53 urinary oxalate 53 thrombotic events 53 hyperemesis 53 RAS inhibitors 53 cardioprotective effects 53 cardiovascular disease 53 corticosteroid therapy 53 retrograde ejaculation 53 fat diets 53 aspirin therapy 53 invasive ductal 53 proliferative diabetic retinopathy 53 STRIDE PD 53 nonmelanoma skin cancer 53 density lipoprotein HDL cholesterol 53 autoantibody positive 53 DHA supplementation 53 RCTs 53 intensive statin therapy 53 hemorrhagic strokes 53 impaired fasting glucose 53 bone density 53 undergoing hysterectomy 53 overt hepatic encephalopathy HE 53 conjugated equine estrogen 53 placenta praevia 53 lowest tertile 53 improves insulin sensitivity 53 Framingham Offspring Study 53 antidepressant therapy 53 fasting insulin 53 reproductive hormones 53 randomized clinical trials 53 magnesium supplementation 53 Vitamin D supplements 53 GSTM1 53 VTE 53 urinary tract symptoms 53 micrometastases 53 virologic failure 53 irregular menses 53 tumor recurrence 53 subgroup analyzes 53 meta analysis 53 onset diabetes mellitus 53 HIV HCV coinfected 53 NATRECOR ® 53 lipid profiles 53 serum urate levels 53 thyroid stimulating hormone 53 poorer prognosis 53 invasive ductal breast cancer 53 phytoestrogens 53 nondemented 53 habitual snoring 53 adjuvant therapy 53 vitamin D intake 53 A1c levels 53 osteoporosis 53 vulvovaginal atrophy 53 EGFR mutations 53 fibroids 53 prospective cohort 53 LHRH receptor positive 53 multivitamin supplements 53 PSADT 53 #mmHg [001] 53 HER2 expression 53 PSA screening 53 % CI #.#-#.# [003] 53 placental malaria 53 dense breasts 53 dexrazoxane 53 CMV infection 53 vitamin D insufficiency 53 hippocampal volume 53 hormonal treatments 53 estrogen metabolites 53 NHANES III 53 nephron sparing surgery 53 GISTs 53 plasma adiponectin 53 Lp PLA2 53 androgen ablation 53 sexual dysfunction 53 thromboembolisms 53 triglyceride concentrations 53 conjugated estrogen 53 lymph node involvement 53 Fibrates 53 hypertension diabetes mellitus 53 efalizumab 53 Benign Prostatic Hyperplasia 53 Statin therapy 53 nondiabetics 53 fluoxetine Prozac 53 hormonal therapies 53 thromboprophylaxis 53 cryptorchidism 53 tHcy 53 NPH insulin 53 Premenopausal 53 invasive lobular 53 HDL cholesterol 53 thrombotic complications 53 lipoprotein 53 CaP 53 rosuvastatin 53 serous ovarian cancer 53 antiandrogens 53 TEAEs 53 gestational diabetes mellitus GDM 53 Osteoporotic Fractures 53 renal tumors 53 thigh circumference 53 alpha blockers 53 LHRH agonists 53 egg follicles 53 TT genotype 53 inflammatory biomarkers 53 perioperative complications 53 progestins 53 CYP#D# inhibitor 53 indomethacin 53 valvulopathy 53 oropharyngeal cancer 53 serum urate 53 hypertrophic scars 53 vitamin B# deficiency 53 non aspirin NSAIDs 53 pre eclampsia 53 hyperandrogenism 53 calorie diets 53 underwent bariatric surgery 53 arterial thickening 53 IV bisphosphonates 53 peri menopausal women 53 Cristofanilli 53 bioavailable testosterone 53 endometrial lining 53 urate lowering 53 precancerous cervical lesions 53 serum estradiol 53 screening mammography 53 mixed hyperlipidemia 53 RBC folate 53 HbA1C levels 53 Vitamin D supplementation 53 SORT OUT III 53 benign prostatic hyperplasia 53 cirrhotic patients 53 mutated BRCA1 53 artery stenosis 53 postoperative complications 53 thyroid stimulating hormone TSH 53 selective serotonin reuptake inhibitors 53 Avandia Actos 53 cardiovascular disease CVD 53 placebo controlled studies 53 hypovitaminosis D 53 intravesical therapy 53 menopausal 53 rFVIIa 53 SERMs 53 carotid plaques 53 ovarian hyperstimulation syndrome OHSS 53 cutaneous melanoma 53 cardiorespiratory fitness 53 autoimmune thyroiditis 53 venous thromboembolic events 53 telmisartan 53 PREZISTA r 53 Remifemin R 53 antigen PSA levels 53 VA# [002] 53 androgenic hormones 53 adenomatous 53 nulliparous 53 Testosterone gel 53 clinically detectable 53 biochemical markers 53 pyridostigmine 53 pancreatic adenocarcinoma 53 alendronate 53 brain shrinkage 53 primary aldosteronism 53 femoral neck BMD 53 dosage regimens 53 CrCl 53 vaginal hysterectomy 53 neurological abnormalities 53 BRCA1 mutation 53 secondary amenorrhea 53 menstrual migraines 53 relieving menopausal symptoms 53 GnRH agonist 53 index BMI 53 prostate carcinoma 53 menopausal symptom 53 sildenafil Viagra 53 risedronate 53 retrospective cohort 53 gonadotropins 53 ALLHAT 53 FOLFOX4 53 KRAS status 53 drank pomegranate juice 53 euthyroid 53 PCa 53 pioglitazone 53 ovaries removed 53 intra abdominal fat 53 ASCUS 53 cognitively normal 53 sertraline 53 bisphosphonate therapy 53 NMIBC 53 antihypertensive drugs 53 parous 53 basal cell carcinomas 53 serum retinol 53 pre cancerous lesions 53 chromium supplementation 53 #OHD levels 53 vardenafil Levitra 52 antidiabetic medication 52 nmol liter 52 ApoE4 52 postoperative AF 52 lipid lowering agents 52 antioxidant supplementation 52 myocardial infarction 52 Hypogonadism 52 recurrent ovarian 52 irregular menstrual periods 52 LDL cholesterol concentrations 52 induce ovulation 52 chlorambucil 52 overactive bladder OAB 52 symptomatic BPH 52 esophageal squamous cell carcinoma 52 AVANDIA 52 HNPCC 52 irregular ovulation 52 C reactive protein 52 hormone receptor positive 52 Pioglitazone 52 screening colonoscopy 52 #.#mg/dL 52 SHPT 52 IDH1 mutation 52 premenstrual dysphoric disorder PMDD 52 Uterine cancer 52 diabetes mellitus DM 52 KRAS variant 52 androgen suppression 52 biochemical relapse 52 mesotheliomas 52 oesophageal adenocarcinoma 52 Epidemiologic studies 52 EDARBI 52 conventional antipsychotics 52 surgically menopausal 52 gestational diabetes 52 LEXIVA r 52 antioxidant vitamin supplements 52 Henrik Leffers 52 plasma glucose levels 52 dose statin therapy 52 2D 4D ratio 52 EGFR mutation 52 Multivariate analyzes 52 posaconazole 52 ovary removal 52 ICDs implanted 52 RLS sufferers 52 serum parathyroid hormone 52 MGUS 52 perfluorooctanoate PFOA 52 lumbar spine bone 52 luteal 52 microvascular disease 52 ischemic strokes 52 estrogens 52 vitamin B6 52 endocrine therapy 52 bezafibrate 52 baseline HbA1c 52 autonomic dysfunction 52 shorter telomeres 52 CLBP 52 androgen deprivation therapy 52 ductal carcinomas 52 cardioembolic stroke 52 URTI 52 RYGB surgery 52 zoledronic acid 52 ABCB1 52 Raloxifene 52 Prehypertension 52 prostate pancreatic 52 hypothalamic amenorrhea 52 transaminase elevations 52 μg L 52 basal cell skin 52 incontinence episodes 52 Natural S equol 52 NNRTI resistance 52 nonalcoholic steatohepatitis NASH 52 HYVET 52 colon rectal 52 citalopram Celexa 52 uncomplicated pregnancies 52 locoregional recurrence 52 intact parathyroid hormone 52 hypothyroid 52 microscopic hematuria 52 serum TSH 52 familial clustering 52 pheochromocytoma 52 Premenopausal women 52 glycated hemoglobin levels 52 neutrophil counts 52 mammographic screening 52 baseline mammogram 52 ruptured aneurysms 52 squamous histology 52 DEXA scan 52 abdominal fat 52 trans palmitoleic acid 52 ovulatory dysfunction 52 pegylated liposomal doxorubicin 52 axillary node dissection 52 pattern baldness 52 benign growths 52 sUA 52 typical antipsychotics 52 raloxifene 52 5-FU/LV 52 follicular phase 52 oestrogens 52 menstrual bleeding 52 hyperphenylalaninemia HPA due 52 distant metastases 52 celecoxib 52 serum folate 52 androgen excess 52 candesartan cilexetil 52 olaparib 52 perioperatively 52 tamoxifen Nolvadex ® 52 hormone receptor status 52 serum homocysteine 52 ejaculatory dysfunction 52 chemoradiation 52 CIN3 52 muscle dysmorphia